Clostr Perf*2/Clos Others*4 Kb

Verify with FDA CVM →

137 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
137
Total Reports
120
Deaths Reported
8760.0%
Death Rate

Active Ingredients

Clostr Perf*2/Clos Others*4 Kb

Administration Routes

SubcutaneousUnknown

Species Affected

Cattle 137

Most Affected Breeds

Cattle (other) 72
Aberdeen Angus 25
Crossbred Bovine/Cattle 22
Holstein-Friesian also known as Holstein 8
Mixed (Cattle) 4
Cattle (unspecified) 3
Charolais 2
Simmental 1

Most Reported Reactions

Death 111
Lack of efficacy - NOS 73
Lack of efficacy (bacteria) - NOS 15
Respiratory signs 8
Death by euthanasia 7
Necropsy performed 7
Lack of efficacy (endoparasite NOS) 6
Anaphylaxis 6
Laboured breathing 5
NT - Abnormal necropsy finding NOS 5
Pneumonia 5
Lameness 5

Outcome Breakdown

Died
117 (41.5%)
Ongoing
66 (23.4%)
Recovered/Normal
48 (17.0%)
Outcome Unknown
43 (15.2%)
Euthanized
8 (2.8%)

Data Summary

Metric Value
Total adverse event reports 137
Reports involving death 120
Case-fatality rate (reported events) 8760.0%
Distinct species in reports 1
Distinct breeds in reports 8
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clostr Perf*2/Clos Others*4 Kb Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 137 adverse event reports referencing Clostr Perf*2/Clos Others*4 Kb, including 120 reports in which the animal died — a 8760.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Clostr Perf*2/Clos Others*4 Kb. Reported administration routes include Subcutaneous, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clostr Perf*2/Clos Others*4 Kb reports are Cattle (137 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (72), Aberdeen Angus (25), Crossbred Bovine/Cattle (22) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clostr Perf*2/Clos Others*4 Kb are Death (111), Lack of efficacy - NOS (73), Lack of efficacy (bacteria) - NOS (15), Respiratory signs (8). Of the 282 reports with a coded outcome, Died is the leading category at 41.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clostr Perf*2/Clos Others*4 Kb.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial